Wei Hou

Tianjin People's Hospital

Papers

1

Total Citations

22

H-Index

1

About

Wei Hou has made pioneering contributions to the development of advanced three-dimensional (3D) scaffold-based immunoassay platforms, with a primary focus on high-throughput hepatotoxicity evaluation. His most cited work introduces a ready-to-use, versatile, and multiplex-able hydrogel-based chip that overcomes key limitations of traditional 2D assays by enhancing antibody loading capacity and signal amplification. Notably, Hou’s research addresses the critical challenge of mass transfer barriers and sample dilution inherent in high-water-content hydrogels, offering a practical solution for more accurate and efficient protein detection. With over 20 citations on his flagship paper, his work has influenced the design of next-generation diagnostic tools for drug toxicity screening. Hou’s innovations bridge materials science and biomedical engineering, providing a scalable platform for multiplexed analysis in preclinical safety assessment. His contributions are particularly valuable for researchers seeking robust, miniaturized systems that maintain sensitivity while enabling parallel processing—a key step toward personalized medicine and safer pharmaceutical development.

Research Focus

Key Achievements

1
H-Index
1
Papers
22
Total Citations
22
Avg Citations/Paper
🏆 Most Cited Paper
A ready-to-use, versatile, multiplex-able three-dimensional scaffold-based immunoassay chip for high throughput hepatotoxicity evaluation
22 citations · 2015
📈 Most Prolific Year: 2015 (1 Papers)
🤝 Key Collaborators: 7
🏛 Institutions: Tianjin People's Hospital

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago